Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
Dell ends hybrid work policy, becomes latest tech giant to force workers back to the office full-timeFebruary 3, 2025
GROCERY OUTLET INVESTOR NOTICE: Grocery Outlet Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 3, 2025
Share Twitter Facebook LinkedIn Email European countries have been unable to reach agreement on modernisation of the Energy Charter TreatyUK joins France, Spain and the Netherlands in Read More
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
Trump plans to cut US funding to South Africa over land law. Musk has also criticized the countryFebruary 3, 2025
By 
